CORBION NV (CRBN.AS) Stock Fundamental Analysis
AMS:CRBN - Euronext Amsterdam - NL0010583399 - Common Stock - Currency: EUR
Overall CRBN gets a fundamental rating of 6 out of 10. We evaluated CRBN against 66 industry peers in the Chemicals industry. CRBN has an excellent profitability rating, but there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on CRBN. These ratings would make CRBN suitable for value investing!
1. Profitability
1.1 Basic Checks
CRBN had positive earnings in the past year.
In the past year CRBN had a positive cash flow from operations.
In the past 5 years CRBN has always been profitable.
Each year in the past 5 years CRBN had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 12.43%, CRBN belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 24.88%, CRBN belongs to the top of the industry, outperforming 98.48% of the companies in the same industry.
CRBN's Return On Invested Capital of 6.89% is fine compared to the rest of the industry. CRBN outperforms 74.24% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CRBN is in line with the industry average of 6.51%.
The 3 year average ROIC (6.62%) for CRBN is below the current ROIC(6.89%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.43% | ||
| ROE | 24.88% | ||
| ROIC | 6.89% |
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
1.3 Margins
CRBN's Profit Margin of 14.92% is amongst the best of the industry. CRBN outperforms 96.97% of its industry peers.
In the last couple of years the Profit Margin of CRBN has grown nicely.
With a decent Operating Margin value of 7.04%, CRBN is doing good in the industry, outperforming 62.12% of the companies in the same industry.
In the last couple of years the Operating Margin of CRBN has declined.
CRBN's Gross Margin of 24.81% is in line compared to the rest of the industry. CRBN outperforms 40.91% of its industry peers.
In the last couple of years the Gross Margin of CRBN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.04% | ||
| PM (TTM) | 14.92% | ||
| GM | 24.81% |
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
2. Health
2.1 Basic Checks
CRBN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CRBN has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CRBN has been reduced compared to 5 years ago.
CRBN has a better debt/assets ratio than last year.
2.2 Solvency
CRBN has an Altman-Z score of 2.55. This is not the best score and indicates that CRBN is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of CRBN (2.55) is better than 65.15% of its industry peers.
CRBN has a debt to FCF ratio of 5.10. This is a neutral value as CRBN would need 5.10 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 5.10, CRBN is doing good in the industry, outperforming 72.73% of the companies in the same industry.
A Debt/Equity ratio of 0.40 indicates that CRBN is not too dependend on debt financing.
The Debt to Equity ratio of CRBN (0.40) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.4 | ||
| Debt/FCF | 5.1 | ||
| Altman-Z | 2.55 |
ROIC/WACC1.04
WACC6.65%
2.3 Liquidity
A Current Ratio of 1.17 indicates that CRBN should not have too much problems paying its short term obligations.
CRBN has a Current ratio of 1.17. This is amonst the worse of the industry: CRBN underperforms 80.30% of its industry peers.
A Quick Ratio of 0.58 indicates that CRBN may have some problems paying its short term obligations.
With a Quick ratio value of 0.58, CRBN is not doing good in the industry: 87.88% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.17 | ||
| Quick Ratio | 0.58 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 168.39% over the past year.
Measured over the past years, CRBN shows a very strong growth in Earnings Per Share. The EPS has been growing by 49.47% on average per year.
CRBN shows a small growth in Revenue. In the last year, the Revenue has grown by 1.90%.
CRBN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.70% yearly.
EPS 1Y (TTM)168.39%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-47.64%
Revenue 1Y (TTM)1.9%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%4.6%
3.2 Future
Based on estimates for the next years, CRBN will show a very strong growth in Earnings Per Share. The EPS will grow by 27.50% on average per year.
The Revenue is expected to grow by 3.27% on average over the next years.
EPS Next Y55.4%
EPS Next 2Y34.31%
EPS Next 3Y27.5%
EPS Next 5YN/A
Revenue Next Year1.65%
Revenue Next 2Y2.7%
Revenue Next 3Y3.27%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 5.67, which indicates a rather cheap valuation of CRBN.
Based on the Price/Earnings ratio, CRBN is valued cheaper than 100.00% of the companies in the same industry.
CRBN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.91.
With a Price/Forward Earnings ratio of 11.78, the valuation of CRBN can be described as very reasonable.
75.76% of the companies in the same industry are more expensive than CRBN, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.77, CRBN is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.67 | ||
| Fwd PE | 11.78 |
4.2 Price Multiples
68.18% of the companies in the same industry are more expensive than CRBN, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CRBN is valued cheaper than 81.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.75 | ||
| EV/EBITDA | 8.64 |
4.3 Compensation for Growth
CRBN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CRBN may justify a higher PE ratio.
A more expensive valuation may be justified as CRBN's earnings are expected to grow with 27.50% in the coming years.
PEG (NY)0.1
PEG (5Y)0.11
EPS Next 2Y34.31%
EPS Next 3Y27.5%
5. Dividend
5.1 Amount
CRBN has a Yearly Dividend Yield of 3.39%.
CRBN's Dividend Yield is a higher than the industry average which is at 3.12.
CRBN's Dividend Yield is a higher than the S&P500 average which is at 2.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.39% |
5.2 History
The dividend of CRBN has a limited annual growth rate of 5.02%.
Dividend Growth(5Y)5.02%
Div Incr Years1
Div Non Decr Years5
5.3 Sustainability
CRBN pays out 21.80% of its income as dividend. This is a sustainable payout ratio.
CRBN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP21.8%
EPS Next 2Y34.31%
EPS Next 3Y27.5%
AMS:CRBN (5/23/2025, 7:00:00 PM)
18.43
-0.12 (-0.65%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners77.4%
Inst Owner ChangeN/A
Ins Owners0.21%
Ins Owner ChangeN/A
Market Cap1.07B
Analysts76.92
Price Target26.08 (41.51%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.39% |
Yearly Dividend0.71
Dividend Growth(5Y)5.02%
DP21.8%
Div Incr Years1
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.79%
PT rev (3m)-5.79%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.36%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.46%
Revenue NY rev (3m)-3.49%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.67 | ||
| Fwd PE | 11.78 | ||
| P/S | 0.83 | ||
| P/FCF | 10.75 | ||
| P/OCF | 5.83 | ||
| P/B | 1.39 | ||
| P/tB | 1.59 | ||
| EV/EBITDA | 8.64 |
EPS(TTM)3.25
EY17.63%
EPS(NY)1.56
Fwd EY8.49%
FCF(TTM)1.72
FCFY9.31%
OCF(TTM)3.16
OCFY17.15%
SpS22.11
BVpS13.26
TBVpS11.56
PEG (NY)0.1
PEG (5Y)0.11
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.43% | ||
| ROE | 24.88% | ||
| ROCE | 8.18% | ||
| ROIC | 6.89% | ||
| ROICexc | 7.21% | ||
| ROICexgc | 7.95% | ||
| OM | 7.04% | ||
| PM (TTM) | 14.92% | ||
| GM | 24.81% | ||
| FCFM | 7.76% |
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
ROICexc(3y)7.16%
ROICexc(5y)7.83%
ROICexgc(3y)8.31%
ROICexgc(5y)9.44%
ROCE(3y)7.87%
ROCE(5y)8.47%
ROICexcg growth 3Y0.82%
ROICexcg growth 5Y-11.84%
ROICexc growth 3Y3.78%
ROICexc growth 5Y-8.06%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
F-Score8
Asset Turnover0.83
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.4 | ||
| Debt/FCF | 5.1 | ||
| Debt/EBITDA | 1.73 | ||
| Cap/Depr | 97% | ||
| Cap/Sales | 6.54% | ||
| Interest Coverage | 3.61 | ||
| Cash Conversion | 103.72% | ||
| Profit Quality | 51.98% | ||
| Current Ratio | 1.17 | ||
| Quick Ratio | 0.58 | ||
| Altman-Z | 2.55 |
F-Score8
WACC6.65%
ROIC/WACC1.04
Cap/Depr(3y)194.04%
Cap/Depr(5y)192.31%
Cap/Sales(3y)11.51%
Cap/Sales(5y)11.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)168.39%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-47.64%
EPS Next Y55.4%
EPS Next 2Y34.31%
EPS Next 3Y27.5%
EPS Next 5YN/A
Revenue 1Y (TTM)1.9%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%4.6%
Revenue Next Year1.65%
Revenue Next 2Y2.7%
Revenue Next 3Y3.27%
Revenue Next 5YN/A
EBIT growth 1Y44.66%
EBIT growth 3Y8.15%
EBIT growth 5Y1.31%
EBIT Next Year139.88%
EBIT Next 3Y39.25%
EBIT Next 5YN/A
FCF growth 1Y520.5%
FCF growth 3YN/A
FCF growth 5Y21.2%
OCF growth 1Y11.31%
OCF growth 3Y101.81%
OCF growth 5Y9.98%